Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene blue in surgery for hyperparathyroidism
jRCTs031180295Recruiting
- Start
- Oct 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of methylene blue in primary hyperparathyroidism (PHPT) and secondary hyperparathyroidism (SHPT). Primary endpoint: Intraoperative identification rate of parathyroid. Started Oct 2000; status: recruiting.
02
Drugs
methylene blue
03
Conditions
primary hyperparathyroidism (PHPT)secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on jRCTs031180295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180295.